Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: The road toward a new diagnostic tool?

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1922-1929

  Khadjavi, Amina ^a   Barbero, Giovanna ^a   Destefanis, Paolo ^a,c   Mandili, Giorgia ^a   Giribaldi, Giuliana ^a   Mannu, Franca ^a,b   Pantaleo, Antonella ^b   Ceruti, Carlo ^a   Bosio, Andrea ^a   Rolle, Luigi ^a   Turrini, Francesco ^a   Fontana, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Nurex Srl   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

carcinoma, transitional cell; diagnosis; phosphoproteins; tumor markers, biological; urinary bladder

Indexed keywords

PHOSPHOPROTEIN;

ABNORMAL LABORATORY RESULT; ARTICLE; BIOACCUMULATION; BLADDER CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN URINE LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VOLUNTEER;

AGED; BIOPSY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; NEOPLASM STAGING; PHOSPHORYLATION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; TYROSINE; URINARY BLADDER NEOPLASMS;

EID: 79953796880     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.029     Document Type: Article

References (23)

1. M. Burchardt, T. Burchardt, and A. Shabsigh Current concepts in biomarker technology for bladder cancers Clin Chem 46 2000 595
2. V. Lokeshwar, and M. Soloway Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165 2001 1067
3. O. Yossepowitch, H. Herr, and S. Donat Use of urinary biomarkers for bladder cancer surveillance: patient perspectives J Urol 177 2007 1277
4. A. Van Tilborg, C. Bangma, and E. Zwarthoff Bladder cancer biomarkers and their role in surveillance and screening Int J Urol 16 2009 23
5. R. Svatek, and Y. Lotan Is there a rationale for bladder cancer screening? Curr Urol Rep 9 2008 339
6. Y. Lotan, R. Svatek, and A. Sagalowsky Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis Cancer 107 2006 982
7. Y.K. Kim, and W.J. Kim Epigenetic markers as promising prognosticators for bladder cancer Int J Urol 16 2009 17
8. E. Diamandis How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer Clin Chem 50 2004 793
9. B. van Rhijn, H. van derPoel, and T. van derKwast Urine markers for bladder cancer surveillance: a systematic review Eur Urol 47 2005 736
10. M. Ostergaard, H. Wolf, and T. Orntoft Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas Electrophoresis 20 1999 349l
11. H. Iwaki, S. Kageyama, and T. Isono Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis Cancer Sci 95 2004 955
12. O. Vrooman, and J. Witjes Molecular markers for detection, surveillance and prognostication of bladder cancer Int J Urol 16 2009 234
13. Y. Lim Mining the tumor phosphoproteome for cancer markers Clin Cancer Res 11 2005 3163
14. I. Shchemelinin, L. Sefc, and E. Necas Protein kinases, their function and implication in cancer and other diseases Folia Biol (Praha) 52 2006 81
15. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355
16. G. Barbero, F. Carta, and G. Giribaldi Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies Anal Biochem 349 2006 62
17. U. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680
18. L. Sun, S. Sakurai, and T. Sano High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma Pathol Int 59 2009 522
19. R. Jain, S. Fischer, and S. Serra The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver Appl Immunohistochem Mol Morphol 18 2010 9
20. E. Sueoka, Y. Goto, and N. Sueoka Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers Cancer Res 59 1999 1404
21. T. Hwang, H. Choi, and H. Han Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa Eur J Surg Oncol 33 2007 474
22. B. Youn, D. Kim, and J. Kim NM23 as a prognostic biomarker in ovarian serous carcinoma Mod Pathol 21 2008 885
23. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 103 2000 211